Based on its role in promoting a potent, memory-like T cell phenotype, it is predicted that manufacturing with interleukin-15 would lead to CAR T cells that exhibit increased release of effector cytokines (like IFN-γ and TNF-α) upon antigen stimulation compared to CAR T cells made without interleukin-15.